Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Matsoukas

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Journal of Medicinal Chemistry|January 6, 2006
Design, synthesis, and molecular modeling of a novel amide-linked cyclic GnRH analogue cyclo(4-9)[Lys4,D-Trp6,Glu9]GnRH: stimulation of gonadotropin gene expressionMaria K Keramida, Theodore Tselios, Efthimia Mantzourani, et al.
Bioorganic & Medicinal Chemistry|September 3, 2013
Divergent and convergent synthesis of polymannosylated dibranched antigenic peptide of the immunodominant epitope MBP(83-99)Irene Friligou, Fabio Rizzolo, Francesca Nuti, et al.
Journal of Medicinal Chemistry|June 11, 2004
Design and synthesis of novel biologically active thrombin receptor non-peptide mimetics based on the pharmacophoric cluster Phe/Arg/NH2 of the Ser42-Phe-Leu-Leu-Arg46 motif sequence: platelet aggregation and relaxant activitiesKostas Alexopoulos, Panagiotis Fatseas, Euthemia Melissari, et al.
Journal of Medicinal Chemistry|December 5, 2008
Citrullination of linear and cyclic altered peptide ligands from myelin basic protein (MBP(87-99)) epitope elicits a Th1 polarized response by T cells isolated from multiple sclerosis patients: implications in triggering diseaseGeorge Deraos, Kokona Chatzantoni, Minos-Timotheos Matsoukas, et al.
Molecules (Basel, Switzerland)|June 29, 2013
Facile and efficient syntheses of a series of N-benzyl and N-biphenylmethyl substituted imidazole derivatives based on (E)-urocanic acid, as angiotensin II AT1 receptor blockersGeorge Agelis, Konstantinos Kelaidonis, Amalia Resvani, et al.
Experimental Neurology|December 3, 2014
Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitisVivian Tseveleki, Theodore Tselios, Ioannis Kanistras, et al.
Cardiovascular Therapeutics|September 14, 2017
Alamandine reverses hyperhomocysteinemia-induced vascular dysfunction via PKA-dependent mechanismsTawar Qaradakhi, Minos Timotheos Matsoukas, Alan Hayes, et al.
European Journal of Biochemistry|August 5, 2004
NMR and molecular dynamics studies of an autoimmune myelin basic protein peptide and its antagonist: structural implications for the MHC II (I-Au)-peptide complex from docking calculationsAndreas G Tzakos, Patrick Fuchs, Nico A J van Nuland, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2002
Design, synthesis and biological evaluation of cyclic angiotensin II analogues with 3,5 side-chain bridges. Role of C-terminal aromatic residue and ring cluster for activity and implications in the drug design of AT1 non-peptide antagonistsPanagiota Roumelioti, Ludmila Polevaya, Panagiotis Zoumpoulakis, et al.
European Journal of Medicinal Chemistry|June 27, 2015
Properties of myelin altered peptide ligand cyclo(87-99)(Ala91,Ala96)MBP87-99 render it a promising drug lead for immunotherapy of multiple sclerosisGeorge Deraos, Maria Rodi, Hubert Kalbacher, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|January 6, 2006
Design, synthesis, and molecular modeling of a novel amide-linked cyclic GnRH analogue cyclo(4-9)[Lys4,D-Trp6,Glu9]GnRH: stimulation of gonadotropin gene expressionMaria K Keramida, Theodore Tselios, Efthimia Mantzourani, et al.
Bioorganic & Medicinal Chemistry|September 3, 2013
Divergent and convergent synthesis of polymannosylated dibranched antigenic peptide of the immunodominant epitope MBP(83-99)Irene Friligou, Fabio Rizzolo, Francesca Nuti, et al.
Journal of Medicinal Chemistry|June 11, 2004
Design and synthesis of novel biologically active thrombin receptor non-peptide mimetics based on the pharmacophoric cluster Phe/Arg/NH2 of the Ser42-Phe-Leu-Leu-Arg46 motif sequence: platelet aggregation and relaxant activitiesKostas Alexopoulos, Panagiotis Fatseas, Euthemia Melissari, et al.
Journal of Medicinal Chemistry|December 5, 2008
Citrullination of linear and cyclic altered peptide ligands from myelin basic protein (MBP(87-99)) epitope elicits a Th1 polarized response by T cells isolated from multiple sclerosis patients: implications in triggering diseaseGeorge Deraos, Kokona Chatzantoni, Minos-Timotheos Matsoukas, et al.
Molecules (Basel, Switzerland)|June 29, 2013
Facile and efficient syntheses of a series of N-benzyl and N-biphenylmethyl substituted imidazole derivatives based on (E)-urocanic acid, as angiotensin II AT1 receptor blockersGeorge Agelis, Konstantinos Kelaidonis, Amalia Resvani, et al.
Experimental Neurology|December 3, 2014
Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitisVivian Tseveleki, Theodore Tselios, Ioannis Kanistras, et al.
Cardiovascular Therapeutics|September 14, 2017
Alamandine reverses hyperhomocysteinemia-induced vascular dysfunction via PKA-dependent mechanismsTawar Qaradakhi, Minos Timotheos Matsoukas, Alan Hayes, et al.
European Journal of Biochemistry|August 5, 2004
NMR and molecular dynamics studies of an autoimmune myelin basic protein peptide and its antagonist: structural implications for the MHC II (I-Au)-peptide complex from docking calculationsAndreas G Tzakos, Patrick Fuchs, Nico A J van Nuland, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2002
Design, synthesis and biological evaluation of cyclic angiotensin II analogues with 3,5 side-chain bridges. Role of C-terminal aromatic residue and ring cluster for activity and implications in the drug design of AT1 non-peptide antagonistsPanagiota Roumelioti, Ludmila Polevaya, Panagiotis Zoumpoulakis, et al.
European Journal of Medicinal Chemistry|June 27, 2015
Properties of myelin altered peptide ligand cyclo(87-99)(Ala91,Ala96)MBP87-99 render it a promising drug lead for immunotherapy of multiple sclerosisGeorge Deraos, Maria Rodi, Hubert Kalbacher, et al.
Pageof 7